Showing results (1551-1560 of 1,588) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|September 12, 2025
Cutaneous Vasculitis in Primary Sjögren DiseasePaul Breillat, Véronique Le Guern, Thomas d'Humières, et al.
JAMA Dermatology|June 18, 2025
Psoriasis Risk in Patients With Atopic Dermatitis Treated With DupilumabTeng-Li Lin, Yi-Hsuan Fan, Kuo-Sheng Fan, et al.
JAMA Dermatology|March 13, 2024
Prevalence and Patient Characteristics of Ectodermal Dysplasias in DenmarkLaura Krogh Herlin, Sigrun A J Schmidt, Xenia Buus Hermann, et al.
JAMA Dermatology|April 3, 2024
Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne TreatmentRonnie A Festok, Avni S Ahuja, Jared Y Chen, et al.
JAMA Dermatology|March 6, 2024
Symptoms of Cognitive Impairment Among Children With Atopic DermatitisEmily Z Ma, Hannah R Chang, Sarah Radtke, et al.
JAMA Dermatology|July 10, 2024
Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension StudyLisa A Beck, Robert Bissonnette, Mette Deleuran, et al.
JAMA Dermatology|July 17, 2024
Systemic Immunomodulatory Treatments for Atopic Dermatitis: Living Systematic Review and Network Meta-Analysis UpdateAaron M Drucker, Megan Lam, David Prieto-Merino, et al.
JAMA Dermatology|July 24, 2024
Area Deprivation and Disease Severity in Adult Patients With Discoid Lupus ErythematosusDaniella Forman Faden, Lillian Xie, Caroline Stone, et al.
JAMA Dermatology|March 27, 2024
Validation of Thermal Imaging and the ALT-70 Prediction Model to Differentiate Cellulitis From PseudocellulitisMichael S Pulia, Rebecca J Schwei, Roxana Alexandridis, et al.
JAMA Dermatology|April 10, 2024
Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized TrialRose C Velasco, Connie Shao, Brett Cutler, et al.
Pageof 159